Journal
JOURNAL OF ANTIBIOTICS
Volume 63, Issue 8, Pages 423-430Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ja.2010.62
Keywords
antibiotics; natural products; pipeline
Funding
- Italian Ministry of Research
Ask authors/readers for more resources
New antibiotics are necessary to treat microbial pathogens that are becoming increasingly resistant to available treatment. Despite the medical need, the number of newly approved drugs continues to decline. We offer an overview of the pipeline for new antibiotics at different stages, from compounds in clinical development to newly discovered chemical classes. Consistent with historical data, the majority of antibiotics under clinical development are natural products or derivatives thereof. However, many of them also represent improved variants of marketed compounds, with the consequent risk of being only partially effective against the prevailing resistance mechanisms. In the discovery arena, instead, compounds with promising activities have been obtained from microbial sources and from chemical modification of antibiotic classes other than those in clinical use. Furthermore, new natural product scaffolds have also been discovered by ingenious screening programs. After providing selected examples, we offer our view on the future of antibiotic discovery. The Journal of Antibiotics (2010) 63, 423-430, doi 10 1038/ja 2010.62, published online 16 June 2010
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available